129 related articles for article (PubMed ID: 29524408)
41. Thyroglobulin as a negative marker for malignancy in canine and human breast tumors.
Hwang SH; Yang Y; Woo SH; Jung JH; Seo D; Kim DY; Kim Y
Mol Carcinog; 2021 Jul; 60(7):455-468. PubMed ID: 34003526
[TBL] [Abstract][Full Text] [Related]
42. Reduced selenium-binding protein 1 in breast cancer correlates with poor survival and resistance to the anti-proliferative effects of selenium.
Zhang S; Li F; Younes M; Liu H; Chen C; Yao Q
PLoS One; 2013; 8(5):e63702. PubMed ID: 23704933
[TBL] [Abstract][Full Text] [Related]
43. Progesterone stimulates proliferation and promotes cytoplasmic localization of the cell cycle inhibitor p27 in steroid receptor positive breast cancers.
Kariagina A; Xie J; Langohr IM; Opreanu RC; Basson MD; Haslam SZ
Horm Cancer; 2013 Dec; 4(6):381-90. PubMed ID: 23996077
[TBL] [Abstract][Full Text] [Related]
44. Estrogen promotes increased breast cancer cell proliferation and migration through downregulation of CPEB1 expression.
Sovijit W; Sovijit W; Ishii Y; Kambe J; Fujita T; Watanabe G; Yamaguchi H; Nagaoka K
Biochem Biophys Res Commun; 2021 Jan; 534():871-876. PubMed ID: 33162033
[TBL] [Abstract][Full Text] [Related]
45. Role of thioredoxin reductase 1 and thioredoxin interacting protein in prognosis of breast cancer.
Cadenas C; Franckenstein D; Schmidt M; Gehrmann M; Hermes M; Geppert B; Schormann W; Maccoux LJ; Schug M; Schumann A; Wilhelm C; Freis E; Ickstadt K; Rahnenführer J; Baumbach JI; Sickmann A; Hengstler JG
Breast Cancer Res; 2010; 12(3):R44. PubMed ID: 20584310
[TBL] [Abstract][Full Text] [Related]
46. Differential and correlated expressions of p16/p21/p27/p38 in mammary gland tumors of aged dogs.
Kim HW; Ju JH; Shin JI; Seung BJ; Sur JH
J Vet Sci; 2017 Dec; 18(4):479-485. PubMed ID: 28927257
[TBL] [Abstract][Full Text] [Related]
47. GANP protein encoded on human chromosome 21/mouse chromosome 10 is associated with resistance to mammary tumor development.
Kuwahara K; Yamamoto-Ibusuki M; Zhang Z; Phimsen S; Gondo N; Yamashita H; Takeo T; Nakagata N; Yamashita D; Fukushima Y; Yamamoto Y; Iwata H; Saya H; Kondo E; Matsuo K; Takeya M; Iwase H; Sakaguchi N
Cancer Sci; 2016 Apr; 107(4):469-77. PubMed ID: 26749495
[TBL] [Abstract][Full Text] [Related]
48. Targeted inhibition of EG-1 blocks breast tumor growth.
Lu M; Sartippour MR; Zhang L; Norris AJ; Brooks MN
Cancer Biol Ther; 2007 Jun; 6(6):936-41. PubMed ID: 17568184
[TBL] [Abstract][Full Text] [Related]
49. Common plasma protein marker LCAT in aggressive human breast cancer and canine mammary tumor.
Park HM; Kim H; Kim DW; Yoon JH; Kim BG; Cho JY
BMB Rep; 2020 Dec; 53(12):664-669. PubMed ID: 33298249
[TBL] [Abstract][Full Text] [Related]
50. FSIP1 is correlated with estrogen receptor status and poor prognosis.
Li X; Song X; Ma J; Zhao Y; Jiang Q; Zhao Z; Li M
Mol Carcinog; 2020 Jan; 59(1):126-135. PubMed ID: 31713931
[TBL] [Abstract][Full Text] [Related]
51. Nucleostemin reveals a dichotomous nature of genome maintenance in mammary tumor progression.
Lin T; Lin TC; McGrail DJ; Bhupal PK; Ku YH; Zhang W; Meng L; Lin SY; Peng G; Tsai RYL
Oncogene; 2019 May; 38(20):3919-3931. PubMed ID: 30692636
[TBL] [Abstract][Full Text] [Related]
52. Genetic variation in sensitivity to estrogens and breast cancer risk.
Jerry DJ; Shull JD; Hadsell DL; Rijnkels M; Dunphy KA; Schneider SS; Vandenberg LN; Majhi PD; Byrne C; Trentham-Dietz A
Mamm Genome; 2018 Feb; 29(1-2):24-37. PubMed ID: 29487996
[TBL] [Abstract][Full Text] [Related]
53. Expression of TXNIP in Cancer Cells and Regulation by 1,25(OH)₂D₃: Is It Really the Vitamin D₃ Upregulated Protein?
Abu El Maaty MA; Almouhanna F; Wölfl S
Int J Mol Sci; 2018 Mar; 19(3):. PubMed ID: 29534438
[TBL] [Abstract][Full Text] [Related]
54. Phenotypical Characteristics of Chemically Induced Mammary Tumor.
Kabakov AV; Lykov AP; Morozov DV; Kazakov OV; Poveshchenko AF; Raiter TV; Strunkin DN; Konenkov VI
Bull Exp Biol Med; 2017 Aug; 163(4):490-492. PubMed ID: 28853066
[TBL] [Abstract][Full Text] [Related]
55. Bromodomain 4 activation predicts breast cancer survival.
Crawford NP; Alsarraj J; Lukes L; Walker RC; Officewala JS; Yang HH; Lee MP; Ozato K; Hunter KW
Proc Natl Acad Sci U S A; 2008 Apr; 105(17):6380-5. PubMed ID: 18427120
[TBL] [Abstract][Full Text] [Related]
56. Identification and characterization of a proliferative cell population in estrogen receptor-positive metastatic breast cancer through spatial and single-cell transcriptomics.
Yoshitake R; Mori H; Ha D; Wu X; Wang J; Wang X; Saeki K; Chang G; Shim HJ; Chan Y; Chen S
bioRxiv; 2023 Feb; ():. PubMed ID: 36778271
[TBL] [Abstract][Full Text] [Related]
57. MAM domain containing 2 is a potential breast cancer biomarker that exhibits tumour-suppressive activity.
Lee H; Park BC; Soon Kang J; Cheon Y; Lee S; Jae Maeng P
Cell Prolif; 2020 Sep; 53(9):e12883. PubMed ID: 32707597
[TBL] [Abstract][Full Text] [Related]
58. Modelling molecular mechanisms of breast cancer and invasion: lessons from the normal gland.
Bissell MJ
Biochem Soc Trans; 2007 Feb; 35(Pt 1):18-22. PubMed ID: 17212581
[TBL] [Abstract][Full Text] [Related]
59. hnRNP G elicits tumor-suppressive activity in part by upregulating the expression of Txnip.
Shin KH; Kim RH; Kim RH; Kang MK; Park NH
Biochem Biophys Res Commun; 2008 Aug; 372(4):880-5. PubMed ID: 18541147
[TBL] [Abstract][Full Text] [Related]
60. Tumor necrosis factor induces rapid down-regulation of TXNIP in human T cells.
Levring TB; Kongsbak-Wismann M; Rode AKO; Al-Jaberi FAH; Lopez DV; Met Ö; Woetmann A; Bonefeld CM; Ødum N; Geisler C
Sci Rep; 2019 Nov; 9(1):16725. PubMed ID: 31723203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
